XTX Topco’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

XTX Topco’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,404	Closed	-$762K	–	4341
2026 Q1	$762K	Buy	25,404 +2,185	+9%	+$72.4K	0.01%	1655
2025 Q4	$759K	Buy	23,219 +11,162	+93%	+$360K	0.02%	1244
2025 Q3	$418K	Sell	12,057 -27,746	-70%	-$888K	0.02%	1218
2025 Q2	$1.11M	Buy	+39,803	New	+$1.07M	0.05%	597
2025 Q1	–	Sell	-19,833	Closed	-$545K	–	2639
2024 Q4	$545K	Buy	19,833 +11,492	+138%	+$320K	0.04%	703
2024 Q3	$240K	Sell	8,341 -3,111	-27%	-$84.7K	0.02%	1334
2024 Q2	$284K	Buy	+11,452	New	+$325K	0.02%	999
2023 Q2	–	Sell	-8,416	Closed	-$325K	–	1557
2023 Q1	$325K	Buy	+8,416	New	+$346K	0.07%	588

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

XTX Topco's LKFT Position: Q2 2026 in Review

XTX Topco sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 25,404 shares — an estimated $762K sold.

XTX Topco first reported a position in LKFT in Q1 2023 and held it in 8 quarters. The position peaked at $1.11M in Q2 2025. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

XTX Topco reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 25,404 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $762K.
XTX Topco first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 8 quarters.
XTX Topco's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.11M in Q2 2025.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.